These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 8230284)

  • 1. Second cancers among long-term survivors of non-Hodgkin's lymphoma.
    Travis LB; Curtis RE; Glimelius B; Holowaty E; Van Leeuwen FE; Lynch CF; Adami J; Gospodarowicz M; Wacholder S; Inskip P
    J Natl Cancer Inst; 1993 Dec; 85(23):1932-7. PubMed ID: 8230284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of second malignant neoplasms among long-term survivors of testicular cancer.
    Travis LB; Curtis RE; Storm H; Hall P; Holowaty E; Van Leeuwen FE; Kohler BA; Pukkala E; Lynch CF; Andersson M; Bergfeldt K; Clarke EA; Wiklund T; Stoter G; Gospodarowicz M; Sturgeon J; Fraumeni JF; Boice JD
    J Natl Cancer Inst; 1997 Oct; 89(19):1429-39. PubMed ID: 9326912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second cancers following non-Hodgkin's lymphoma.
    Travis LB; Curtis RE; Boice JD; Hankey BF; Fraumeni JF
    Cancer; 1991 Apr; 67(7):2002-9. PubMed ID: 2004317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-up.
    Tadmor T; Liphshitz I; Silverman B; Polliack A
    Hematol Oncol; 2017 Dec; 35(4):599-607. PubMed ID: 27238496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second cancers in patients with chronic lymphocytic leukemia.
    Travis LB; Curtis RE; Hankey BF; Fraumeni JF
    J Natl Cancer Inst; 1992 Sep; 84(18):1422-7. PubMed ID: 1512794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of leukemia following treatment for non-Hodgkin's lymphoma.
    Travis LB; Curtis RE; Stovall M; Holowaty EJ; van Leeuwen FE; Glimelius B; Lynch CF; Hagenbeek A; Li CY; Banks PM
    J Natl Cancer Inst; 1994 Oct; 86(19):1450-7. PubMed ID: 8089863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years.
    Dores GM; Metayer C; Curtis RE; Lynch CF; Clarke EA; Glimelius B; Storm H; Pukkala E; van Leeuwen FE; Holowaty EJ; Andersson M; Wiklund T; Joensuu T; van't Veer MB; Stovall M; Gospodarowicz M; Travis LB
    J Clin Oncol; 2002 Aug; 20(16):3484-94. PubMed ID: 12177110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012).
    Baras N; Dahm S; Haberland J; Janz M; Emrich K; Kraywinkel K; Salama A
    Br J Haematol; 2017 Apr; 177(2):226-242. PubMed ID: 28106907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second cancer risk following Hodgkin's disease: a 20-year follow-up study.
    van Leeuwen FE; Klokman WJ; Hagenbeek A; Noyon R; van den Belt-Dusebout AW; van Kerkhoff EH; van Heerde P; Somers R
    J Clin Oncol; 1994 Feb; 12(2):312-25. PubMed ID: 8113838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second cancer after the treatment for Hodgkin's disease: a report from the International Database on Hodgkin's Disease.
    Henry-Amar M
    Ann Oncol; 1992 Sep; 3 Suppl 4():117-28. PubMed ID: 1450072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of subsequent solid tumors after non-Hodgkin's lymphoma: effect of diagnostic age and time since diagnosis.
    Hemminki K; Lenner P; Sundquist J; Bermejo JL
    J Clin Oncol; 2008 Apr; 26(11):1850-7. PubMed ID: 18347006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence.
    Metayer C; Lynch CF; Clarke EA; Glimelius B; Storm H; Pukkala E; Joensuu T; van Leeuwen FE; van't Veer MB; Curtis RE; Holowaty EJ; Andersson M; Wiklund T; Gospodarowicz M; Travis LB
    J Clin Oncol; 2000 Jun; 18(12):2435-43. PubMed ID: 10856104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-time risk patterns of solid cancers in 60 901 non-Hodgkin lymphoma survivors from Finland, Norway and Sweden.
    Lorenzo Bermejo J; Pukkala E; Johannesen TB; Sundquist J; Hemminki K
    Br J Haematol; 2014 Mar; 164(5):675-83. PubMed ID: 24528128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma.
    Tward JD; Wendland MM; Shrieve DC; Szabo A; Gaffney DK
    Cancer; 2006 Jul; 107(1):108-15. PubMed ID: 16708354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second malignancies after Hodgkin's disease: the Munich experience.
    Munker R; Grützner S; Hiller E; Aydemir U; Enne W; Dietzfelbinger H; Busch M; Haas R; Emmerich B; Schmidt M; Dühmke E; Hölzel D; Wilmanns W
    Ann Hematol; 1999 Dec; 78(12):544-54. PubMed ID: 10647878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma.
    Travis LB; Curtis RE; Glimelius B; Holowaty EJ; Van Leeuwen FE; Lynch CF; Hagenbeek A; Stovall M; Banks PM; Adami J
    J Natl Cancer Inst; 1995 Apr; 87(7):524-30. PubMed ID: 7707439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV).
    Wheeler C; Khurshid A; Ibrahim J; Elias A; Mauch P; Ault K; Antin J
    Leuk Lymphoma; 2001 Feb; 40(5-6):499-509. PubMed ID: 11426523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease.
    van Leeuwen FE; Somers R; Taal BG; van Heerde P; Coster B; Dozeman T; Huisman SJ; Hart AA
    J Clin Oncol; 1989 Aug; 7(8):1046-58. PubMed ID: 2754447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
    Schaapveld M; Aleman BM; van Eggermond AM; Janus CP; Krol AD; van der Maazen RW; Roesink J; Raemaekers JM; de Boer JP; Zijlstra JM; van Imhoff GW; Petersen EJ; Poortmans PM; Beijert M; Lybeert ML; Mulder I; Visser O; Louwman MW; Krul IM; Lugtenburg PJ; van Leeuwen FE
    N Engl J Med; 2015 Dec; 373(26):2499-511. PubMed ID: 26699166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis.
    Rueffer U; Josting A; Franklin J; May M; Sieber M; Breuer K; Engert A; Diehl V;
    J Clin Oncol; 2001 Apr; 19(7):2026-32. PubMed ID: 11310450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.